Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome

Biomarkers

Volumn 17, Issue 3, 2012, Pages 248-253

  Feng, Xuewei ^a   Li, Peng ^a   Zhou, Chuming ^a   Jia, Xi ^a   Kang, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemerin; Inflammation; Obesity; Obstructive sleep apnea syndrome

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CHEMERIN; INSULIN;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; CHEMOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 84860377697     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.658864     Document Type: Article

References (31)

1. Acioglu E, Yigit O, Volkan Sunter A, Taskin U, Berç ik Inal B, Sahin M. (2010). Obesity and obstructive sleep apnea syndrome. J Otolaryngol Head Neck Surg 39:744-751.
2. Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. (2011). Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 6:120-125.
3. Berg V, Sveinbjörnsson B, Bendiksen S, Brox J, Meknas K, Figenschau Y. (2010). Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ther 12:R228.
4. Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK. (2009). TNF-α gene polymorphism and TNF-α levels in obese Asian Indians with obstructive sleep apnea. Respir Med 103:386-392.
5. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. (2007). Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148:4687-4694. (Pubitemid 47481514)
6. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW, Collier G, Blangero J, Walder K, Jowett JB. (2009). Chemerin is associated with metabolic syndrome phenotypes in a Mexican- American population. J Clin Endocrinol Metab 94:3085-3088.
7. Deegan PC, McNicholas WT. (1995). Pathophysiology of obstructive sleep apnoea. Eur Respir J 8:1161-1178.
8. Dong B, Ji W, Zhang Y. (2011). Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50:1093-1097.
9. Dupont WD, Plummer WD Jr. (1990). Power and sample size calculations. A review and computer program. Control Clin Trials 11:116-128. (Pubitemid 20136185)
10. Eisinger K, Bauer S, Schäffler A, Walter R, Neumann E, Buechler C, Müller-Ladner U, Frommer KW. (2011). Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Pathol 92:90-96.
11. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ. (2007). Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282:28175-28188. (Pubitemid 47529521)
12. Hart R, Greaves DR. (2010). Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 185:3728-3739.
13. Hasler G, Buysse DJ, Klaghofer R, Gamma A, Ajdacic V, Eich D, Rössler W, Angst J. (2004). The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27:661-666. (Pubitemid 38823362)
14. Hu W, Feng P. (2011). Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 91:159-163.
15. Kent BD, Ryan S, McNicholas WT. (2011). Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 178:475-481.
16. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, Lebherz C, Tittus J, Reiser M, Becker C, Göke B, Leber AW, Parhofer KG, Broedl UC. (2009). Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 161:339-344.
17. Lurie A. (2011). Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol 46:1-42.
18. Madani M, Madani F. (2009). Epidemiology, pathophysiology, and clinical features of obstructive sleep apnea. Oral Maxillofac Surg Clin North Am 21:369-375.
19. Malhotra A, White DP. (2002). Obstructive sleep apnoea. Lancet 360:237-245. (Pubitemid 34804656)
20. Masserini B, Morpurgo PS, Donadio F, Baldessari C, Bossi R, Beck- Peccoz P, Orsi E. (2006). Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 29:700-705. (Pubitemid 44756174)
21. Pack AI. (2006). Advances in sleep-disordered breathing. Am J Respir Crit Care Med 173:7-15. (Pubitemid 43069783)
22. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. (2000). Longitudinal study of moderate weight change and sleepdisordered breathing. JAMA 284:3015-3021. (Pubitemid 32014738)
23. Punjabi NM. (2008). The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136-143. (Pubitemid 351237871)
24. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, Sasaki S. (2007). Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 362:1013-1018. (Pubitemid 47390675)
25. Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. (2010). Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 137:711-719.
26. Stejskal D, Karpisek M, Hanulova Z, Svestak M. (2008). Chemerin is an independent marker of the metabolic syndrome in a Caucasian population - a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:217-221.
27. Sunitha C, Aravindkumar S. (2009). Obstructive sleep apnea: clinical and diagnostic features. Indian J Dent Res 20:487-491.
28. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schäffler A, Aslanidis C, Schölmerich J, Buechler C. (2010). Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 72:342-348.
29. Yamamoto T, Qureshi AR, Anderstam B, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, Axelsson J. (2010). Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 25:4017-4023.
30. Yamamoto Y, Fujiuchi S, Hiramatsu M, Nishigaki Y, Takeda A, Fujita Y, Yamazaki Y. (2008). Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 76:377-385.
31. Ye J, Liu H, Li Y, Liu X, Zhu JM. (2007). Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J 120:1482-1486. (Pubitemid 47496582)